Day: January 23, 2026

FORT WORTH, TX, Jan. 23, 2026 (GLOBE NEWSWIRE) — Sanara MedTech Inc. (“Sanara MedTech,” “Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market, today reported certain unaudited preliminary financial results for the fourth quarter and full year ended December 31, 2025, and introduced its financial guidance for the full year ending December 31, 2026. Selected Fourth Quarter and Full Year 2025 Preliminary Financial Results (Unaudited):Net revenue for the fourth quarter of 2025 is expected to be in the range of $27.2 million to $27.7 million, an increase of approximately 3% to 5%, compared to $26.3 million in the fourth quarter of 2024.As...

SIM0505 (CDH6 ADC) Phase 1 dose escalation data update anticipated in Q2 2026 LNCB74 (B7-H4 ADC) Phase 1 dose escalation expanded into higher dose cohortsBELTSVILLE, Md., Jan. 23, 2026 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to developing novel therapies to treat cancer, today provided updates for its two antibody drug conjugate (ADC) programs and reported a preliminary year-end 2025 cash position. SIM0505 (CDH6 ADC): Phase 1 dose escalation data expected in Q2 2026SIM0505 is a novel ADC directed to cadherin-6 (CDH6 ADC), which is overexpressed in several cancers with limited expression in healthy tissues. SIM0505 features a proprietary topoisomerase 1 inhibitor (TOPOi) payload, designed for broad anti-tumor activity, fast systemic clearance and an improved potential...

– Sparta and Warrenton Nursing Facilities and Related Property Sold for $13.18 Million – DENVER, Jan. 23, 2026 (GLOBE NEWSWIRE) — Selectis Health, Inc. (OTC: GBCS) (“Selectis” or the “Company”) announced its wholly-owned subsidiaries, Providence HR, LLC and Atl/Warr, LLC (each a “Seller”), have completed the sale of two properties located in Georgia, including the skilled nursing facilities known as Providence of Sparta Health & Rehab (collectively, “the Sparta Facility”), located in Sparta, Georgia, as well as Warrenton Health & Rehabilitation (collectively, “the Warrenton Facility”), located in Warrenton, Georgia. This sale was officially completed on January 15, 2026 and is the consummation of a definitive Purchase and Sale Agreement (the “PSA”) originally announced on December 9,...

PORTLAND, Tenn., Jan. 23, 2026 (GLOBE NEWSWIRE) — Shoals Technologies Group, Inc. (the “Company”) (Nasdaq: SHLS) today announced that the Company will release its fourth quarter and full year 2025 results before market open on Tuesday, February 24, 2026, to be followed by a conference call at 8:00 a.m. (Eastern Time) on the same day. Interested investors and other parties can access the live webcast through the Investor Relations section of the Company’s website at https://investors.shoals.com. An archived replay of the webcast will be available shortly after the event concludes. About Shoals Technologies Group, Inc.Shoals Technologies Group is a leading manufacturer of advanced electrical infrastructure solutions for mission‑critical applications across utility‑scale solar, battery storage, and data center power systems....

VANCOUVER, British Columbia, Jan. 23, 2026 (GLOBE NEWSWIRE) — Almadex Minerals Ltd. (“Almadex” or the “Company”) (TSX-V: “DEX”) is pleased to discuss the Company’s 2025 exploration program and its plans for 2026. While the Company holds important assets in Canada such as the Logan Zn-Ag project (see Almadex news release of July 25, 2025), its current exploration efforts are focussed on precious and base metals in the western USA. A large amount of successful generative work was completed in 2025 resulting in several new early-stage project acquisitions. At the same time the Company’s existing exploration project portfolio was significantly advanced. The Company anticipates that 2026 will be a significant year, with first pass drilling programs being planned for several projects within its portfolio. The...

Jersey stitches together hockey history from every province and territory to celebrate Our Game TORONTO, Jan. 23, 2026 (GLOBE NEWSWIRE) — Rogers today proudly unveiled The Great Canadian Jersey, a symbol of national unity and the latest instalment of Rogers This Is Our Game campaign.Handcrafted by former OHL player turned fashion designer Cameron Lizotte, the patchwork design brings together pieces of hockey jerseys sourced from every province and territory in Canada to represent all facets of the sport and our country’s deep history with the game. After donating his own jersey to kickstart a donation drive that saw hundreds of hockey jerseys contributed from across Canada, Team Rogers athlete and Edmonton Oilers Captain Connor McDavid was first to try on The Great Canadian Jersey. Photos here. “The Great Canadian Jersey is an...

VANCOUVER, British Columbia, Jan. 23, 2026 (GLOBE NEWSWIRE) — Stallion Uranium Corp. (the “Company” or “Stallion”) (TSX-V: STUD; OTCQB: STLNF; FSE: B76) is pleased to announce the mobilization of an expanded high-resolution ground gravity survey on its Coyote Target corridor, located in the Athabasca Basin of northern Saskatchewan, Canada. The current program is designed to extend the results of Stallion’s previous ground gravity survey by expanding coverage to the west of the original survey area. Mobilization is commencing, with the objective of identifying additional gravity lows and refining the geometry and continuity of anomalies identified at the margins of the earlier survey. Highlights:The expanded survey aims to identify additional gravity lows associated with interpreted density destruction in the basement rocks, which...

MONTREAL, Jan. 23, 2026 (GLOBE NEWSWIRE) — Osisko Development Corp. (NYSE: ODV, TSXV: ODV) (“Osisko Development” or the “Company“) regrets to report that on January 22, 2026, a contractor working at surface suffered a fatal injury following an isolated incident at the Cariboo Gold Project (the “Project“), located in central British Columbia (“B.C.“), Canada. The Company promptly notified appropriate authorities, and an investigation of the incident is underway. Sean Roosen, Chairman and CEO, stated: “We are deeply saddened by this tragic accident and extend our heartfelt condolences and support to our colleague’s family, friends and coworkers during this difficult time. The health, safety and wellbeing of all employees and contractors working at the Project is our highest...

Data from eight participants continue to support safety and tolerability profile of tegoprubart Mean eGFR increased over the measurement period, from 67.0 mL/min/1.73 m² at 12 months to 74.2 mL/min/1.73 m² at 24 months IRVINE, Calif., Jan. 23, 2026 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that it will present 24-month follow-up data from eight patients enrolled in the Phase 1b trial long-term extension evaluating tegoprubart in kidney transplantation at the American Society of Transplant Surgeons Winter Symposium, taking place January 23–25, 2026, in Scottsdale, Arizona. There were no episodes of biopsy-proven acute rejection, graft loss, death, new-onset diabetes mellitus, or de novo donor-specific antibody formation during the study period. Mean estimated glomerular filtration...